Skip to main content
P

Precision Biosensor Inc. — Investor Relations & Filings

Ticker · 335810 ISIN · KR7335810008 KO Manufacturing
Open in API
Filings indexed 172 across all filing types
Latest filing 2020-11-27 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 335810

About Precision Biosensor Inc.

https://precision-bio.com/

Precision Biosensor Inc. is an in vitro diagnostics (IVD) company that develops, manufactures, and commercializes clinical diagnostic solutions. The company specializes in point-of-care testing (POCT), providing optimized systems for on-site diagnosis. Its product portfolio includes analyzing devices and diagnostic reagents for both human and animal health. Precision Biosensor utilizes advanced technologies, such as time-resolved fluorescence (TRF), for the sensitive and accurate detection of various disease biomarkers in immuno-diagnosis and clinical chemistry applications, including cardiac markers.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a '정정신고(보고)' (Amendment Report) for a '증권신고서' (Securities Registration Statement) filed by Precision Biosensor (프리시젼바이오). In the context of Korean financial regulations (FSC/FSS), a Securities Registration Statement is a formal regulatory filing required for public offerings or IPOs. Since this is an amendment to a registration statement, it falls under the category of Regulatory Filings (RNS) as it is a formal submission to the regulatory body regarding the company's offering process.
2020-11-27 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Supervisory Service (FSS) in South Korea. It contains detailed information regarding a company's public offering, including business risks, financial projections, and share structure. The document explicitly states it is a 'Correction Report' (정정신고) to a previously filed registration statement. In the context of financial filings, a Securities Registration Statement is a primary regulatory document for capital raising, which falls under the 'Regulatory Filings' category as it is a formal filing with the regulatory body.
2020-11-26 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details the public offering of shares for Precision Bio, including investment risks, offering terms, and financial information. This is a formal regulatory filing required for an IPO or capital raise, which falls under the 'POS' (Share Issue/Capital Change) or 'RNS' (Regulatory Filing) category. Given the specific nature of a Securities Registration Statement for a new share issuance, 'POS' is the most accurate classification for a capital-raising event involving the issuance of new shares.
2020-11-17 Korean
감사보고서 (2019.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for Precision Bio Inc. It includes the independent auditor's report, balance sheet, income statement, statement of changes in equity, cash flow statement, and detailed notes to the financial statements for the fiscal year 2019. While it contains an audit report, the document is a full set of audited financial statements, which is the primary component of an Annual Report (10-K equivalent in the Korean regulatory context). FY 2019
2020-04-06 Korean
연결감사보고서 (2019.12)
Annual Report Classification · 1% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Precision Bio Inc. for the fiscal year ending December 31, 2019. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. As it contains the full audited financial statements for a specific fiscal period, it is classified as an Annual Report (10-K equivalent in this context). FY 2019
2020-04-06 Korean
감사보고서 (2018.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for 'Precision Bio' (프리시젼바이오 주식회사) covering the fiscal years 2017 and 2018. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Comprehensive Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. While it contains financial data, it is a formal audit report rather than a standalone Annual Report (10-K) or a simple Earnings Release. In the context of financial reporting, this is classified as an Audit Report. FY 2018
2019-04-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.